Literature DB >> 790914

Effects of some naturally occurring prostaglandins and synthetic analogues on gastric secretion and ulcer healing in man.

S M Karim, W P Fung.   

Abstract

The effects of several naturally occurring prostaglandins and their synthetic analogues on gastric acid secretion in man have been studied. Naturally occurring prostaglandins when given orally do not inhibit gastric secretion in man with the exceptions of PGA2, PGB1, and PGB2. The effect of PGB compounds in inhibiting gastric secretion is inconsistent and unpredictable, whereas PGA2 produces only a transient inhibition of acid secretion. Several synthetic analogues of prostaglandin E2 (particularly 15-methyl and 16,16-dimethyl analogues) produce a marked and sustained inhibition of acid secretion in man when administered orally. In a double-blind study 15(R)-15 methyl-PGE2 has been shown to be highly effective in healing of gastric ulcers in man possibly by inhibiting gastric acid and pepsin secretion and stimulating mucus production. Prostaglandin E2 (although without effect on gastric acid secretion in man) is also effective in healing of gastric ulcers. Deficiency of prostaglandins as a possible cause of gastrointestinal ulcers is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 790914

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Res        ISSN: 0361-5952


  10 in total

1.  Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

2.  The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients.

Authors:  W Peterson; M Feldman; I Taylor; M Bremer
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

Review 3.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

4.  Role of prostaglandin E2 on human gastric ulcers.

Authors:  K Kobayashi; T Arakawa; H Nakamura; S Chono; H Yamada; T Kamata; T Ono
Journal:  Gastroenterol Jpn       Date:  1982

5.  Activation of human large bowel adenylate cyclase by methylated prostaglandin E2 analogues.

Authors:  B Simon; K R Koczorek; H Kather
Journal:  Klin Wochenschr       Date:  1979-04-17

6.  Role of prostaglandin E2 on gastric ulcers induced by non-steroidal anti-inflammatory compounds (NOSAC).

Authors:  K Kobayashi; T Arakawa; H Nakamura; S Chono; H Yamada; T Kamata; T Ono
Journal:  Gastroenterol Jpn       Date:  1981-12

7.  Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

8.  Protective action of endogenous prostacyclin (PGI2) and prostaglandin E2 (PGE2) in endoscopic polypectomy-induced human ulcers.

Authors:  K Kobayashi; T Arakawa; H Nakamura; S Chono; H Yamada; H Satoh; T Kamata; T Ono
Journal:  Gastroenterol Jpn       Date:  1982-10

9.  Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study.

Authors:  D L Brand; W M Roufail; A B Thomson; E J Tapper
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

10.  The pathogenesis of the aspirin-related gastric lesion.

Authors:  J M Duggan
Journal:  J R Coll Physicians Lond       Date:  1981-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.